Insulin Resistance Syndrome

From Citizendium
Revision as of 01:28, 13 November 2007 by imported>Pierre-Alain Gouanvic (Formatting, reference)
Jump to navigation Jump to search

The insulin resistance syndrome is a "constellation of findings, including central obesity, glucose intolerance, dyslipidemia, and hypertension, that promotes the development of type 2 diabetes mellitus, cardiovascular disease, cancer, polycystic ovary syndrome (PCOS), and nonalcoholic fatty liver disease".[1]

As obesity has reached epidemic proportions in many countries of the developed world, a pattern of these findings has become recognized. Also called the metabolic syndrome, the dysmetabolic syndrome, or syndrome X, this association of physiologic findings is the focus of current research in medicine.

References

  1. Biddinger SB, Kahn CR (2006). "From mice to men: insights into the insulin resistance syndromes". Annu. Rev. Physiol. 68: 123–58. DOI:10.1146/annurev.physiol.68.040104.124723. PMID 16460269. Research Blogging.